Clinical Trials Browser

Interventional × remetinostat × Clear all

NCT03180528 2021-06-08

Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer

Phase 2 Completed

30 enrolled 10 charts

Carcinoma, Basal Cell

NCT03875859 2021-05-20

Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)

Phase 2 Terminated

4 enrolled 9 charts

Carcinoma, Squamous Cell